Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Sanchez

Showing results (1-10 of 454) with videos related to

Pageof 46
Sort By:
Current Stem Cell Research & Therapy|September 11, 2008
Brain tumour stem cells: implications for cancer therapy and regenerative medicineManuel Sanchez-Martin
Acta Paediatrica (Oslo, Norway : 1992)|April 11, 2016
How useful and feasible are early biochemical markers of bronchopulmonary dysplasia?Manuel Sanchez Luna
Politics and the Life Sciences : the Journal of the Association for Politics and the Life Sciences|May 17, 2019
Darwin's politics of selectionLuis Manuel Sanchez
Expert Opinion on Pharmacotherapy|December 14, 2007
Efficacy and safety of bimatoprost/timolol fixed combination in the treatment of glaucoma or ocular hypertensionAntonio Martinez, Manuel Sanchez
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 21, 2008
Retrobulbar hemodynamic parameters in pseudoexfoliation syndrome and pseudoexfoliative glaucomaAntonio Martinez, Manuel Sanchez
Bipolar Disorders|December 17, 2015
In MemoriamManuel Sanchez de Carmona,
Current Medical Research and Opinion|May 24, 2007
A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucomaAntonio Martinez, Manuel Sanchez
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2007
It all happens between Toll receptors and caspase 1Manuel Sanchez-Alavez, Tamas Bartfai
Acta Ophthalmologica|October 6, 2009
Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucomaAntonio Martínez, Manuel Sanchez-Salorio
Therapeutic Delivery|August 26, 2015
Overview of challenges and opportunities in drug delivery and pharmaceuticsRiccardo Panicucci, Manuel Sanchez-Felix
Pageof 46

Showing results (1-10 of 454) with videos related to

Sort By:
Pageof 46
Current Stem Cell Research & Therapy|September 11, 2008
Brain tumour stem cells: implications for cancer therapy and regenerative medicineManuel Sanchez-Martin
Acta Paediatrica (Oslo, Norway : 1992)|April 11, 2016
How useful and feasible are early biochemical markers of bronchopulmonary dysplasia?Manuel Sanchez Luna
Politics and the Life Sciences : the Journal of the Association for Politics and the Life Sciences|May 17, 2019
Darwin's politics of selectionLuis Manuel Sanchez
Expert Opinion on Pharmacotherapy|December 14, 2007
Efficacy and safety of bimatoprost/timolol fixed combination in the treatment of glaucoma or ocular hypertensionAntonio Martinez, Manuel Sanchez
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 21, 2008
Retrobulbar hemodynamic parameters in pseudoexfoliation syndrome and pseudoexfoliative glaucomaAntonio Martinez, Manuel Sanchez
Bipolar Disorders|December 17, 2015
In MemoriamManuel Sanchez de Carmona,
Current Medical Research and Opinion|May 24, 2007
A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucomaAntonio Martinez, Manuel Sanchez
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2007
It all happens between Toll receptors and caspase 1Manuel Sanchez-Alavez, Tamas Bartfai
Acta Ophthalmologica|October 6, 2009
Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucomaAntonio Martínez, Manuel Sanchez-Salorio
Therapeutic Delivery|August 26, 2015
Overview of challenges and opportunities in drug delivery and pharmaceuticsRiccardo Panicucci, Manuel Sanchez-Felix
Pageof 46